Literature DB >> 26045821

Two SNPs of ATP-binding cassette B1 gene on the risk and prognosis of colorectal cancer.

Fei Wang1, Zonghai Huang2, Kehong Zheng2, Haiping Zhao3, Wenxiu Hu3.   

Abstract

We conducted a case-control study to investigate the role of ABCB1 C3435T and G2677T/A in the susceptibility and prognosis of colorectal cancer patients. A total of 316 patients with colorectal cancer and 316 controls were collected between January 2009 and January 2011. Genotyping of ABCB1 C3435T and G2677T/A was conducted by the methods of Polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP). Conditional logistic regression analysis showed that subjects carrying CT and CC genotypes of ABCB1 C3435T were more frequently observed in colorectal cancer patients when compared with controls, and the adjusted ORs were 1.62 (1.05-2.52) and 2.05 (1.25-3.36), respectively. By Cox regression analysis, we found that the TT genotype of ABCB1 C3435T was significantly associated with shorter PFS and OS in patients with colorectal cancer when compared with CC genotype, with adjusted HR (95% CI) of 2.57 (1.14-6.04) and 2.54 (1.05-6.61), respectively. We found that the ABCB1 C3435T polymorphism could affect the susceptibility and clinical outcome of colorectal cancer patients.

Entities:  

Keywords:  ATP-binding cassette B1 gene; clinical outcome; colorectal cancer; susceptibility

Mesh:

Substances:

Year:  2015        PMID: 26045821      PMCID: PMC4440130     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  24 in total

1.  Increased burden of colorectal cancer in Asia.

Authors:  Mohamad Amin Pourhoseingholi
Journal:  World J Gastrointest Oncol       Date:  2012-04-15

2.  Associations of ABCB1 and XPC genetic polymorphisms with susceptibility to colorectal cancer and therapeutic prognosis in a Chinese population.

Authors:  Ai-Min Yue; Zhen-Bin Xie; Hong-Feng Zhao; Shu-Ping Guo; Yu-Hou Shen; Hai-Pu Wang
Journal:  Asian Pac J Cancer Prev       Date:  2013

3.  [Correlation of MDR1 and ABCG2 genetic polymorphisms with the efficacy and adverse events of irinotecan chemotherapy in patients with colorectal cancer].

Authors:  Zhi-wei Sun; Xi-cheng Wang; Jing Gao; Jie Li; Yan-yan Li; Yun-zhi Dang; Lin Shen
Journal:  Zhonghua Wei Chang Wai Ke Za Zhi       Date:  2013-06

4.  Pharmacogenetics of ABC and SLC transporters in metastatic colorectal cancer patients receiving first-line FOLFIRI treatment.

Authors:  Elena De Mattia; Giuseppe Toffoli; Jerry Polesel; Mario D'Andrea; Giuseppe Corona; Vittorina Zagonel; Angela Buonadonna; Eva Dreussi; Erika Cecchin
Journal:  Pharmacogenet Genomics       Date:  2013-10       Impact factor: 2.089

Review 5.  Multiple drug resistance, antimutagenesis and anticarcinogenesis.

Authors:  Lynnette R Ferguson; Silvio De Flora
Journal:  Mutat Res       Date:  2005-08-08       Impact factor: 2.433

6.  Differential toxicity biomarkers for irinotecan- and oxaliplatin-containing chemotherapy in colorectal cancer.

Authors:  Lucía Cortejoso; María I García; Pilar García-Alfonso; Eva González-Haba; Fernando Escolar; María Sanjurjo; Luis A López-Fernández
Journal:  Cancer Chemother Pharmacol       Date:  2013-03-31       Impact factor: 3.333

7.  The influence of genetic polymorphisms in MDR1 gene on breast cancer risk factors in Chinese.

Authors:  Yunhe Jia; Wenjing Tian; Shuai Sun; Peng Han; Weinan Xue; Mingqi Li; Yanlong Liu; Shixiong Jiang; Binbin Cui
Journal:  Med Oncol       Date:  2013-05-21       Impact factor: 3.064

Review 8.  Colorectal cancer: how emerging molecular understanding affects treatment decisions.

Authors:  Meera Sridharan; Joleen M Hubbard; Axel Grothey
Journal:  Oncology (Williston Park)       Date:  2014-02       Impact factor: 2.990

9.  Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study.

Authors:  Vibeke Andersen; Mette Ostergaard; Jane Christensen; Kim Overvad; Anne Tjønneland; Ulla Vogel
Journal:  BMC Cancer       Date:  2009-11-21       Impact factor: 4.430

10.  Low ABCB1 gene expression is an early event in colorectal carcinogenesis.

Authors:  Vibeke Andersen; Ulla Vogel; Sine Godiksen; Franz B Frenzel; Mona Sæbø; Julian Hamfjord; Elin Kure; Lotte K Vogel
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

View more
  8 in total

1.  Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells.

Authors:  Ning Ji; Yuqi Yang; Chao-Yun Cai; Zi-Ning Lei; Jing-Quan Wang; Pranav Gupta; Suneet Shukla; Suresh V Ambudkar; Dexin Kong; Zhe-Sheng Chen
Journal:  Cancer Lett       Date:  2018-10-10       Impact factor: 8.679

2.  Association between MDR1 C3435T polymorphism and colorectal cancer risk: A meta-analysis.

Authors:  Shan-Shan Jin; Wei-Juan Song
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

3.  Haplotype Analysis of MDR1 and Risk for Cervical Cancer in Northeastern Thailand

Authors:  Sophida Phuthong; Wannapa Settheetham-Ishida; Sitakan Natphopsuk; Dariwan Settheetham; Takafumi Ishida
Journal:  Asian Pac J Cancer Prev       Date:  2017-07-27

4.  A meta-analysis of MDR1 polymorphisms rs1128503 and rs1045642 and susceptibility to hepatocellular carcinoma.

Authors:  Qing Chang; Zhong-Lin He; Yu-Chong Peng; Shi-Gang Duan; Yu-Xin Dai; Xiao-Hui Zhao
Journal:  J Int Med Res       Date:  2019-06-24       Impact factor: 1.671

5.  ABCB1 variants C3435T and T129C are not associated with colorectal cancer risk.

Authors:  Areej M Al Qahtani; Ayat B Al-Ghafari; Huda A Al Doghaither; Anas H Alzahrani; Ulfat M Omar; Sawsan A Rahimulddin
Journal:  Afr Health Sci       Date:  2019-09       Impact factor: 0.927

6.  The MDR1/ABCB1 gene rs 1045642 polymorphism in colorectal cancer.

Authors:  Beata Mrozikiewicz-Rakowska; Marian Malinowski; Piotr Nehring; Joanna Bartkowiak-Wieczorek; Anna Bogacz; Ewa Żurawińska-Grzelka; Przemysław Krasnodębski; Jacek Muszyński; Tomasz Grzela; Adam Przybyłkowski; Leszek Czupryniak
Journal:  Arch Med Sci       Date:  2019-09-26       Impact factor: 3.318

7.  Association between MDR1 polymorphisms and XELIRI and XELOX chemoresistance in Saudi patients with colorectal cancer.

Authors:  Ayat B Al-Ghafari; Areej M Al Qahtani; Suzan N Alturki; Huda A Al Doghaither; Ekramy M Elmorsy; Hanaa M Tashkandi; Atlal M Abusanad; Shadi S Alkhayyat; Ulfat M Omar; Ahmed A Zeeneldin
Journal:  Oncol Lett       Date:  2020-08-24       Impact factor: 2.967

8.  Association between ABCB1 (3435C>T) polymorphism and susceptibility of colorectal cancer: A meta-analysis.

Authors:  Li-Li Han; Bai-le Zuo; Wei-Liang Cai; Zhen-Ni Guo; Bing-Hua Tong; Hui-Lian Wei; Zheng Zhu; Guo-Yin Li
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.